Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
An innovative technology for robust high-productivity processes will be established and scaled-up. A compendium of the knowledge gathered regarding mixed substrate cultivation will be made available.
Patented drug formulations of a phthalocyanine photosensitiser based on microfludised lipids in a gel are being developed for photodynamic therapy of tumours together with non-coherent and coherent light sources suitable for the market.
Patented microcrystalized hydrophobic phtalocyanine liposomal drug form plus nayf4 (dopped by yb and er) nanoparticle drug form with matching lasers will be developed, converting 980 nm to 670 nm and enabling unlimited light penetration for infrared pdt curing tumors/metastases in any location.